Home
/
VYCOR MEDICAL INC
/
Financials
/
Quarterly
VYCOR MEDICAL INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that VYCOR MEDICAL INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$301.7K
Aug 10, 2018
Q1
2018
Mar 31, 2018
$325.1K
May 11, 2018
Q3
2017
Sep 30, 2017
$379.1K
Nov 13, 2017
Q2
2018
Jun 30, 2017
$307.7K
Aug 10, 2018
Q1
2018
Mar 31, 2017
$428.4K
May 11, 2018
Q3
2017
Sep 30, 2016
$325.8K
Nov 13, 2017
Q2
2017
Jun 30, 2016
$379.4K
Aug 11, 2017
Q1
2017
Mar 31, 2016
$400.1K
May 11, 2017
Q3
2016
Sep 30, 2015
$242.9K
Nov 14, 2016
Q2
2016
Jun 30, 2015
$286.0K
Aug 9, 2016
Q1
2016
Mar 31, 2015
$328.6K
Apr 28, 2016
Q3
2015
Sep 30, 2014
$334.3K
Nov 13, 2015
Q2
2015
Jun 30, 2014
$298.5K
Aug 14, 2015
Q1
2015
Mar 31, 2014
$358.1K
May 15, 2015
Q3
2014
Sep 30, 2013
$321.6K
Nov 12, 2014
Q2
2014
Jun 30, 2013
$235.0K
Aug 12, 2014
Q1
2014
Mar 31, 2013
$231.7K
May 15, 2014
Q3
2013
Sep 30, 2012
$220.1K
Nov 15, 2013
Q2
2013
Jun 30, 2012
$265.4K
Aug 14, 2013
Q1
2013
Mar 31, 2012
$432.6K
May 15, 2013
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$513.8K
Nov 14, 2025
Q2
2025
Jun 30, 2025
$496.4K
Aug 8, 2025
Q1
2025
Mar 31, 2025
$436.4K
May 15, 2025
Q3
2025
Sep 30, 2024
$390.9K
Nov 14, 2025
Q2
2025
Jun 30, 2024
$406.3K
Aug 8, 2025
Q1
2025
Mar 31, 2024
$337.0K
May 15, 2025
Q3
2024
Sep 30, 2023
$308.6K
Nov 13, 2024
Q2
2024
Jun 30, 2023
$482.8K
Aug 13, 2024
Q1
2024
Mar 31, 2023
$361.0K
May 15, 2024
Q3
2023
Sep 30, 2022
$310.0K
Nov 13, 2023
Q2
2023
Jun 30, 2022
$327.9K
Aug 11, 2023
Q1
2023
Mar 31, 2022
$313.8K
May 12, 2023
Q3
2022
Sep 30, 2021
$332.1K
Nov 14, 2022
Q2
2022
Jun 30, 2021
$491.4K
Aug 15, 2022
Q1
2022
Mar 31, 2021
$295.7K
May 10, 2022
Q3
2021
Sep 30, 2020
$275.9K
Nov 12, 2021
Q2
2021
Jun 30, 2020
$244.3K
Aug 16, 2021
Q1
2021
Mar 31, 2020
$330.2K
May 14, 2021
Q3
2020
Sep 30, 2019
$322.9K
Nov 13, 2020
Q2
2020
Jun 30, 2019
$411.9K
Aug 17, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$4.9K
Nov 14, 2025
Q2
2025
Jun 30, 2025
$23.9K
Aug 8, 2025
Q1
2025
Mar 31, 2025
($38.6K)
May 15, 2025
Q3
2025
Sep 30, 2024
($59.8K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($10.0K)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($30.6K)
May 15, 2025
Q3
2024
Sep 30, 2023
($51.9K)
Nov 13, 2024
Q2
2024
Jun 30, 2023
$68.4K
Aug 13, 2024
Q1
2024
Mar 31, 2023
$6.9K
May 15, 2024
Q3
2023
Sep 30, 2022
($114.8K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($99.0K)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($74.6K)
May 12, 2023
Q3
2022
Sep 30, 2021
$3.7K
Nov 14, 2022
Q2
2022
Jun 30, 2021
($9.4K)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($242.9K)
May 10, 2022
Q3
2021
Sep 30, 2020
($198.3K)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($248.9K)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($174.9K)
May 14, 2021
Q3
2020
Sep 30, 2019
($209.6K)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($185.3K)
Aug 17, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$32.1K
Nov 14, 2025
Q2
2025
Jun 30, 2025
$51.1K
Aug 8, 2025
Q1
2025
Mar 31, 2025
($12.8K)
May 15, 2025
Q3
2025
Sep 30, 2024
($35.1K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
$16.2K
Aug 8, 2025
Q1
2025
Mar 31, 2024
($9.5K)
May 15, 2025
Q3
2024
Sep 30, 2023
($25.5K)
Nov 13, 2024
Q2
2024
Jun 30, 2023
$96.5K
Aug 13, 2024
Q1
2024
Mar 31, 2023
$33.2K
May 15, 2024
Q3
2023
Sep 30, 2022
($88.0K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($74.4K)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($52.9K)
May 12, 2023
Q3
2022
Sep 30, 2021
($88.4K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
$23.5K
Aug 15, 2022
Q1
2022
Mar 31, 2021
($206.8K)
May 10, 2022
Q3
2021
Sep 30, 2020
($206.4K)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($199.4K)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($146.7K)
May 14, 2021
Q3
2020
Sep 30, 2019
($165.7K)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($130.5K)
Aug 17, 2020